Clorox (CLX) stock
NYSE
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $12.1B
- As of Nov 5, 2026
- P/E
- 17.82x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 1.68x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $12.1B
- As of Nov 5, 2026
- P/E
- 17.82x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 1.68x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
17.82x
P/B
—
P/S
1.68x
Earnings and dividend metrics▾
Earnings
EPS
$5.60
Earnings per share
BPS
—
Book value per share
ROE
—
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $5.60 per share.
Dividends
Dividend per share
$4.98
Payout ratio
88.9%
Consecutive years
17+ yrs
Dividend per share and payout ratio are for fiscal 2026.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $498.00 before tax.
- Payout ratio — 88.9% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 17 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2027 Q1)
Revenue increased 33.3% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $1.43B+33.3%
$1.76B
Jul–Sep '24
$1.43B
Jul–Sep '25
$1.91B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 2, 2026.
- Earnings per share increased 113.8% from the same quarter a year earlier.
- Revenue increased 33.3% from the same quarter a year earlier.
- Net income increased 112.5% from the same quarter a year earlier.
Filed Nov 2, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Breber Pierre RDirector · Nov 4, 2026Open-market purchase4,000 shares · $400KAvg. price $100.062722,000 shares held after
- Rendle Linda JChief Executive Officer · Oct 5, 2026Grant or award29,352 shares · $2.4MAvg. price $80.41282,488 shares held after
- Rendle Linda JChief Executive Officer · Oct 5, 2026Shares withheld for taxes12,681 shares · $1.0MAvg. price $80.41
Show 2 price lots
- 11,989 shares × $80.41$964K
- 692 shares × $80.41$56K
- Hilt Angela CEVP - Chief Legal Officer · Oct 5, 2026Grant or award6,637 shares · $534KAvg. price $80.4174,414 shares held after
- Marriner KirstenEVP - Chief Admin Officer · Oct 5, 2026Grant or award6,637 shares · $534KAvg. price $80.4183,591 shares held after
- Hyder Chris TEVP-Chief Operating Officer · Oct 5, 2026Grant or award4,191 shares · $337KAvg. price $80.4194,618 shares held after
- Hilt Angela CEVP - Chief Legal Officer · Oct 5, 2026Shares withheld for taxes4,647 shares · $374KAvg. price $80.41
Show 2 price lots
- 2,351 shares × $80.41$189K
- 2,296 shares × $80.41$185K
- Marriner KirstenEVP - Chief Admin Officer · Oct 5, 2026Shares withheld for taxes4,093 shares · $329KAvg. price $80.41
Show 2 price lots
- 2,142 shares × $80.41$172K
- 1,951 shares × $80.41$157K
- Bellet LucEVP - Chief Financial Officer · Oct 5, 2026Grant or award1,677 shares · $135KAvg. price $80.4176,471 shares held after
- Hyder Chris TEVP-Chief Operating Officer · Oct 5, 2026Shares withheld for taxes1,632 shares · $131KAvg. price $80.41
Show 2 price lots
- 1,532 shares × $80.41$123K
- 100 shares × $80.41$8K
- Peck Laurene EVP - CAO & Corp Controller · Oct 5, 2026Grant or award1,172 shares · $94KAvg. price $80.4110,386 shares held after
- Barton NinaEVP-Chief Growth & Strategy Of · Oct 5, 2026Shares withheld for taxes1,106 shares · $89KAvg. price $80.4136,179 shares held after
- Bellet LucEVP - Chief Financial Officer · Oct 5, 2026Shares withheld for taxes1,611 shares · $130KAvg. price $80.41
Show 2 price lots
- 1,031 shares × $80.41$83K
- 580 shares × $80.41$47K
- Peck Laurene EVP - CAO & Corp Controller · Oct 5, 2026Shares withheld for taxes369 shares · $30KAvg. price $80.41
Show 2 price lots
- 339 shares × $80.41$27K
- 30 shares × $80.41$2K
- Rendle Linda JChief Executive Officer · Sep 23, 2026Grant or award50,988 shares · $4.3MAvg. price $83.94252,149 shares held after
- Hyder Chris TEVP-Chief Operating Officer · Sep 23, 2026Grant or award13,342 shares · $1.1MAvg. price $83.9490,202 shares held after
- Marriner KirstenEVP - Chief Admin Officer · Sep 23, 2026Grant or award12,389 shares · $1.0MAvg. price $83.9476,683 shares held after
- Bellet LucEVP - Chief Financial Officer · Sep 23, 2026Grant or award11,913 shares · $1,000KAvg. price $83.9474,669 shares held after
- Hilt Angela CEVP - Chief Legal Officer · Sep 23, 2026Grant or award11,436 shares · $960KAvg. price $83.9467,547 shares held after
- Barton NinaEVP-Chief Growth & Strategy Of · Sep 23, 2026Grant or award10,721 shares · $900KAvg. price $83.9437,164 shares held after
- Peck Laurene EVP - CAO & Corp Controller · Sep 23, 2026Grant or award2,192 shares · $184KAvg. price $83.949,160 shares held after
- Barton NinaEVP-Chief Growth & Strategy Of · Jul 22, 2026Shares withheld for taxes1,681 shares · $161KAvg. price $95.6926,443 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary10-QClorox said net sales for the quarter ended September 30, 2026 rose 33% from the year-ago period, and volume rose 31%. The company cited lapping lower shipments in the prior year after incremental shipments tied to the ERP transition, and the benefit of the GOJO acquisition, as the main factors.Published Nov 2, 2026 · Filed Nov 2, 2026Read the summary →
- AI summary8-KClorox said its board appointed Fabian Garcia as CEO and a director on October 28, 2026, effective January 5, 2027. Linda Rendle will step down as CEO, chair and director on that date and serve as a senior advisor through April 2, 2027.Published Oct 29, 2026 · Filed Oct 29, 2026Read the summary →
- AI summary8-KThe company entered into a $1,000,000,000 364-Day revolving credit agreement and a $1,250,000,000 delayed draw term credit agreement on March 6, 2026 in connection with its acquisition of GOJO Industries, Inc., the maker of PURELL.Published Oct 16, 2026 · Filed Mar 10, 2026Read the summary →
- Clorox said net sales for the quarter ended September 30, 2026 rose 33% from the year-ago period, and volume rose 31%. The company cited lapping lower shipments in the prior year after incremental shipments tied to the ERP transition, and the benefit of the GOJO acquisition, as the main factors.Read the full analysis →
- Clorox said its board appointed Fabian Garcia as CEO and a director on October 28, 2026, effective January 5, 2027. Linda Rendle will step down as CEO, chair and director on that date and serve as a senior advisor through April 2, 2027.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Clorox (CLX) stock information
NYSE
Clorox (CLX) is listed on NYSE. Its market capitalization is about $12.1B. On trailing-twelve-month earnings the P/E ratio is 17.82. These figures are computed in-house from official filings and are reference information only.
Clorox — frequently asked questions
- What is the P/E ratio of Clorox (CLX)?
- On a trailing-twelve-month basis, CLX trades at a P/E ratio of 17.82. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Clorox?
- CLX has a market capitalization of about $12.1B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.